Published: 2019-07-09

Foreword

The nutraceuticals: a new therapeutic strategy in the management of digestive and respiratory disorders

Giorgio Ciprandi, Salvo Emanuele Aragona, Lorenzo Drago, Ignazio La Mantia
Abstract 115 | PDF Downloads 74 | DOI https://doi.org/10.23750/abm.v90i7-S.8648

Page 5-7

Original articles

Abincol® (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01), an oral nutraceutical, pragmatic use in patients with chronic intestinal disorders

Luigi Bonavina, Andrea Arini, Leonardo Ficano, Donato Iannuzziello, Luigi Pasquale, Salvo Emanuele Aragona, Giorgio Ciprandi, Italian Study Group on digestive disorders
Abstract 197 | PDF Downloads 80 | DOI https://doi.org/10.23750/abm.v90i7-S.8649

Page 8-12

Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, and Lactobacillus delbrueckii LDD01) in patients undergoing bowel preparation

Luigi Bonavina, Andrea Ariani, Leonardo Ficano, Domenico Iannuzziello, Luigi Pasquale, Salvo Emanuele Aragona, Lorenzo Drago, Giorgio Ciprandi, Italian Study Group on digestive disorders
Abstract 149 | PDF Downloads 68 | DOI https://doi.org/10.23750/abm.v90i7-S.8650

Page 13-17

Post-surgical intestinal dysbiosis: use of an innovative mixture (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01)

Luigi Bonavina, Andrea Arini, Leonardo Ficano, Donato Iannuzziello, Luigi Pasquale, Salvo Emanuele Aragona, Giorgio Ciprandi, Italian Study Group on digestive disorders
Abstract 101 | PDF Downloads 57 | DOI https://doi.org/10.23750/abm.v90i7-S.8651

Page 18-23

Broncalt®, class II medical device, in patients with acute upper airways disease: a survey in clinical practice

Gian Franco Cupido, Matteo Gelardi, Ignazio La Mantia, Salvo Emanuele Aragona, Claudio Vicini, Giorgio Ciprandi, Italian Study Group on inflammatory otorhinolaryngological disorders
Abstract 101 | PDF Downloads 67 | DOI https://doi.org/10.23750/abm.v90i7-S.8654

Page 24-29

Broncalt®, class II medical device, in patients with chronic upper airways disease: a survey in clinical practice

Gian Franco Cupido, Matteo Gelardi, Ignazio La Mantia, Salvo Emanuele Aragona, Claudio Vicini, Giorgio Ciprandi, Italian Study Group on inflammatory otorhinolaryngological disorders
Abstract 96 | PDF Downloads 45 | DOI https://doi.org/10.23750/abm.v90i7-S.8655

Page 30-35

Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice

Gian Franco Cupido, Matteo Gelardi, Ignazio La Mantia, Salvo Emanuele Aragona, Claudio Vicini, Giorgio Ciprandi, Italian Study Group on inflammatory otorhinolaryngological disorders
Abstract 88 | PDF Downloads 42 | DOI https://doi.org/10.23750/abm.v90i7-S.8656

Page 36-40

VAS for assessing the perception of antihistamines use in allergic rhinitis

Giorgio Ciprandi, Ignazio La Mantia
Abstract 57 | PDF Downloads 43 | DOI https://doi.org/10.23750/abm.v90i7-S.8657

Page 41-44

Influence of cigarette smoking on allergic rhinitis: a comparative study on smokers and non-smokers

Calogero Grillo, Ignazio La Mantia, Caterina M Grillo, Giorgio Ciprandi, Martina Ragusa, Claudio Andaloro
Abstract 141 | PDF Downloads 81 | DOI https://doi.org/10.23750/abm.v90i7-S.8658

Page 45-51

Oral health in children with sleep-disordered breathing: a cross-sectional study

Calogero Grillo, Ignazio La Mantia, Graziano Zappala, Salvatore Cocuzza, Giorgio Ciprandi, Claudio Andaloro
Abstract 136 | PDF Downloads 80 | DOI https://doi.org/10.23750/abm.v90i7-S.8661

Page 52-59